Shares of Abcam plc (ABCM), a supplier of life science research tools, are rising more than 8% Friday morning after the company said it has decided to explore strategic alternatives, including sale.
The company received strategic inquiries from multiple parties over the past few weeks, Abcam had disclosed earlier.
"Our Board is fully aligned in its belief that the best way to maximize value for shareholders is to comprehensively review the Company's strategic alternatives, including a potential sale of Abcam," the company said.
ABCM is at $22.00 currently. It has traded in the range of $12.48 - $22.59 in the last 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.